Key Financials
 
Key financials

Selected Key Figures*

The fiscal year of HELLA ends on May 31.

* Please observe the remarks on the Yearly Figures.

02/05/2016
Sales
EBITDA
EBIT
Earning
Net financial dept
Equity

Yearly figures

in € million 2016/2017 2015/2016 2014/2015
Sales 6,585 6,352 5,835
Change compared to previous period
[curency- and portfolio adjusted]
4% [4%] 9% [8%] 9% [7%]
EBIT [adjusted] 507 [534] 420 [476] 430 [445]
Change compared to previous period 21% [12%] -2% [7%] 24% [12%]
EBITDA [adjusted] 919 [946] 816 [858] 766 [781]
Change compared to previous period  13% [10%] 7% [10%] 17% [10%]
Earning for the period 343 272 295
Change compared to previous period  26% -8% 29%
Earnings per share (in €) 3.08 2.42 2.70
Change compared to previous period  27% -11% 21%
R&D expenses 636 623 544
Change compared to previous period 2% 15% 6%
Free Cashflow [adjusted] 69 [149] 76 [155] 142 [158]
Net capital expediture 517 463 347
       
EBIT margin [adjusted] 7.7% [8.1%] 6.6% [7.5%] 7.4% [7.6%]
EBITDA margin [adjusted] 14.0% [14.4%] 12.8% [13.5%] 13.1% [13.4%]
R&D expenses in relation to sales 9.7% 9.8% 9.3%
Net financial debt 278 238 131
Net financial debt/EBITDA (last 12 months) 0.3x 0.3x 0.2x
Equity ratio 39.5% 39.6% 38.8%
Return on equity (last 12 months) 17.3% 14.2% 22.0%
Number of employees (headcount) 37,716 33,689 31,864

 

For further informations, please refer to the Consolidated Financial Statement

08/10/2017
 
 

Half year figures

in € million 1st half year
FY 2017/2018
1st half year
FY 2016/2017
Sales 3,452 3,198
Change compared to previous period
[curency- and portfolio adjusted]
8% [9.3%] 1% [2.4%]
EBIT [adjusted] 290 [293] 245 [268]
Change compared to previous period 18% [9%] 21% [5%]
EBITDA [adjusted] 504 [508] 438 [461]
Change compared to previous period  15% [10%] 10% [6%]
Earning for the period 199 174
Change compared to previous period  14% 32%
Earnings per share (in €) 1.78 1.56
Change compared to previous period  14% 34%
R&D expenses 339 311
Change compared to previous period 9% 7%
Free Cashflow
from operating activities [adjusted]
73 [91] 0 [74]
Net capital expediture 213 208
Change compared to previous period 3% 10%
     
EBIT margin [adjusted] 8.4% [8.5%] 7.7% [8.4%]
EBITDA margin [adjusted] 14.6% [14.7%] 13.7% [14.4%]
R&D expenses in relation to sales 9.8% 9.7%
Net capital expediture in relation to sales 6.2% 6.5%
     
  30. Nov 17 31. May 17
Net financial debt 315 278
Net financial debt/EBITDA (last 12 months) 0.3x 0.3x
Equity ratio 41.7% 39.5%
Return on equity (last 12 months) 17.8% 17.3%
Number of employees (headcount) 39,523 37,716

 

Further information can be found in the condensed interim consolidated financial statements and in the further notes.

01/11/2018
 
 

Quarterly figures

in € million 2nd quarter 
FY 2017/2018
2nd quarter
FY 2016/2017
Sales 1,823 1,645
Change compared to previous period
[curency- and portfolio adjusted]
10.8% [12.6%] -1% [-0.1%]
EBIT [adjusted] 166 [168] 129 [150]
Change compared to previous period 29% [12%] -4% [-3%]
EBITDA [adjusted] 276 [278] 228 [249]
Change compared to previous period 21% [11%] 1% [1%]
Earnings for the period 116 90
Change compared to previous period 29% 2%
Earnings per share (in €) 1.04 0.81
Change compared to previous period 29% 3%
R&D expenses 176 157
Change compared to previous period 12% 3%
Free cashflow from
operating activities [adjusted]
27 [41] 37 [43]
Net capital expenditure 69 102
Change compared to previous period -33% 23%
     
EBIT margin [adjusted] 9.1% [9.2%] 7.8% [9.1%]
EBITDA margin 15.1% [15.2%] 13.9% [15.2%]
R&D expenses in relation to sales 9.7% 9.5%
Net capital expediture in relation to sales 3.8% 6.6%

 

Further information can be found in the financial information for the quarter and in the further notes.

01/11/2018
 
 

Sales by business segments

Sales by business segments

As of May 31, 2017

 
 

Regional market coverage

Regional market coverage

As of May 31, 2017

 
 

Employees by regions

Employees by regions

As of May 31, 2017

 
 
 
 
  • icon_druck
  • Youtube
  • linkedin-logo
 
 
 
Financial calendar
2018-03-22Results Third Quarter 2017/18
10/02/2017
2018-08-10Annual Results 2017/18
10/02/2017
 
07/28/2016
Contact

Dr. Kerstin Dodel
Investor Relations
Phone: +49 2941 38 1349
Fax: +49 2941 38 477099
Email: investor.relations@hella.com

 
08/30/2017
Email Service

Register for our Email Service providing access to different HELLA publications.

 
08/30/2017
Stock Chart
 
05/30/2017